GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (OTCPK:LOVFF) » Definitions » Net Intangibles Purchase And Sale

Cannara Biotech (Cannara Biotech) Net Intangibles Purchase And Sale : $0.00 Mil (TTM As of Feb. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Net Intangibles Purchase And Sale?

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Cannara Biotech's net Intangibles purchase and sale for the three months ended in Feb. 2024 was $0.00 Mil. Its net Intangibles purchase and sale for the trailing twelve months (TTM) ended in Feb. 2024 was $0.00 Mil.

Cannara Biotech Net Intangibles Purchase And Sale Historical Data

The historical data trend for Cannara Biotech's Net Intangibles Purchase And Sale can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Net Intangibles Purchase And Sale Chart

Cannara Biotech Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Net Intangibles Purchase And Sale
Get a 7-Day Free Trial -0.21 -0.10 - - -

Cannara Biotech Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Net Intangibles Purchase And Sale Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cannara Biotech Net Intangibles Purchase And Sale Calculation

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Net Intangibles Purchase And Sale for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannara Biotech Net Intangibles Purchase And Sale Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Net Intangibles Purchase And Sale provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (Cannara Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (OTCPK:LOVFF) » Definitions » Net Intangibles Purchase And Sale
Comparable Companies
TSXV:RX XCNQ:INNO TSX:CRDL TSX:CPH XCNQ:GRIN XCNQ:JUSH XCNQ:AYR.A TSX:OGI TSXV:ZYUS TSXV:DB ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
8CB0:Germany LOVE:Canada
Address
1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3
Website
http://www.cannara.ca
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .